LEMD3 gene

Last updated on: 27.01.2023

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).

Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The LEMD3 gene (LEMD3 stands for: LEM Domain Containing 3) encodes the inner nuclear membrane protein Man1, which is localized to chromosome 12q14.3. The encoded protein antagonizes TGF-beta induced cell proliferation arrest. Furthermore, the encoded protein may act as a specific repressor of TGF-beta, activin, and BMP signaling through its interaction with R-SMAD proteins.

Two transcript variants encoding different isoforms were found for the LEMD3 gene. Mutations in this gene have been associated with

Buschke-Ollendorff syndrome

and

Melorheostosis associated with osteopoikilosis.

Note(s)This section has been translated automatically.

Of note in a familial LEMD3 mutation is the case description of osteopoikilosis associated with late-onset localized morphea-type scleroderma (Korman B et al. 2016). DNA sequencing of this case revealed a previously undescribed nonsense mutation (Trp621X) in the LEMD3 gene encoding Man1.

LiteratureThis section has been translated automatically.

Korman B et al. (2016) Mutation in LEMD3 (Man1) Associated with Osteopoikilosis and Late-Onset Generalized Morphea: A New Buschke-Ollendorf Syndrome Variant. Case Rep Dermatol Med. 2016:2483041.

Last updated on: 27.01.2023